{"id":"https://openalex.org/W1978532273","doi":"https://doi.org/10.1093/cid/ciu304","title":"Effectiveness of Clindamycin and Intravenous Immunoglobulin, and Risk of Disease in Contacts, in Invasive Group A Streptococcal Infections","display_name":"Effectiveness of Clindamycin and Intravenous Immunoglobulin, and Risk of Disease in Contacts, in Invasive Group A Streptococcal Infections","publication_year":2014,"publication_date":"2014-04-29","ids":{"openalex":"https://openalex.org/W1978532273","doi":"https://doi.org/10.1093/cid/ciu304","mag":"1978532273","pmid":"https://pubmed.ncbi.nlm.nih.gov/24785239"},"language":"en","primary_location":{"id":"doi:10.1093/cid/ciu304","doi":"https://doi.org/10.1093/cid/ciu304","is_oa":false,"landing_page_url":"https://doi.org/10.1093/cid/ciu304","pdf_url":null,"source":{"id":"https://openalex.org/S72350973","display_name":"Clinical Infectious Diseases","issn_l":"1058-4838","issn":["1058-4838","1537-6591"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Infectious Diseases","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W1978532273"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://research-repository.uwa.edu.au/en/publications/e8c6ee00-d6f6-48e2-8a9f-6567210db2a0","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5023976277","display_name":"Jonathan Rhys Carapetis","orcid":"https://orcid.org/0000-0002-1182-9792","observed_orcids":["https://orcid.org/0000-0002-1182-9792"]},"institutions":[{"id":"https://openalex.org/I175234967","display_name":"The Kids Research Institute Australia","ror":"https://ror.org/01dbmzx78","country_code":"AU","type":"nonprofit","lineage":["https://openalex.org/I175234967"]},{"id":"https://openalex.org/I177877127","display_name":"The University of Western Australia","ror":"https://ror.org/047272k79","country_code":"AU","type":"education","lineage":["https://openalex.org/I177877127"]}],"countries":["AU"],"is_corresponding":false,"raw_author_name":"J. R. Carapetis","raw_affiliation_strings":["Telethon Kids Institute, Centre for Child Health Research, University of Western Australia, Perth"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Telethon Kids Institute, Centre for Child Health Research, University of Western Australia, Perth","institution_ids":["https://openalex.org/I175234967","https://openalex.org/I177877127"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5107842439","display_name":"Peter Jacoby","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I175234967","display_name":"The Kids Research Institute Australia","ror":"https://ror.org/01dbmzx78","country_code":"AU","type":"nonprofit","lineage":["https://openalex.org/I175234967"]},{"id":"https://openalex.org/I177877127","display_name":"The University of Western Australia","ror":"https://ror.org/047272k79","country_code":"AU","type":"education","lineage":["https://openalex.org/I177877127"]}],"countries":["AU"],"is_corresponding":false,"raw_author_name":"P. Jacoby","raw_affiliation_strings":["Telethon Kids Institute, Centre for Child Health Research, University of Western Australia, Perth"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Telethon Kids Institute, Centre for Child Health Research, University of Western Australia, Perth","institution_ids":["https://openalex.org/I175234967","https://openalex.org/I177877127"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5044647001","display_name":"Kylie S Carville","orcid":"https://orcid.org/0000-0002-3663-8802","observed_orcids":["https://orcid.org/0000-0002-3663-8802"]},"institutions":[{"id":"https://openalex.org/I4210088630","display_name":"Victorian Infectious Diseases Reference Laboratory","ror":"https://ror.org/005ynf375","country_code":"AU","type":"facility","lineage":["https://openalex.org/I4210088630"]}],"countries":["AU"],"is_corresponding":false,"raw_author_name":"K. Carville","raw_affiliation_strings":["Victorian Infectious Diseases Reference Laboratory"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Victorian Infectious Diseases Reference Laboratory","institution_ids":["https://openalex.org/I4210088630"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5071126922","display_name":"Seong-Jin Joel Ang","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I165779595","display_name":"The University of Melbourne","ror":"https://ror.org/01ej9dk98","country_code":"AU","type":"education","lineage":["https://openalex.org/I165779595"]}],"countries":["AU"],"is_corresponding":false,"raw_author_name":"S.-J. J. Ang","raw_affiliation_strings":["University of Melbourne General Practice and Primary Health Care Academic Centre"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Melbourne General Practice and Primary Health Care Academic Centre","institution_ids":["https://openalex.org/I165779595"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5079507328","display_name":"Nigel C Curtis","orcid":"https://orcid.org/0000-0003-3446-4594","observed_orcids":["https://orcid.org/0000-0003-3446-4594"]},"institutions":[{"id":"https://openalex.org/I1321649718","display_name":"Royal Children's Hospital","ror":"https://ror.org/02rktxt32","country_code":"AU","type":"healthcare","lineage":["https://openalex.org/I1321649718"]},{"id":"https://openalex.org/I165779595","display_name":"The University of Melbourne","ror":"https://ror.org/01ej9dk98","country_code":"AU","type":"education","lineage":["https://openalex.org/I165779595"]},{"id":"https://openalex.org/I4210150290","display_name":"Murdoch Children's Research Institute","ror":"https://ror.org/048fyec77","country_code":"AU","type":"nonprofit","lineage":["https://openalex.org/I4210150290"]}],"countries":["AU"],"is_corresponding":false,"raw_author_name":"N. Curtis","raw_affiliation_strings":["University of Melbourne Department of Paediatrics, Murdoch Childrens Research Institute and Royal Children's Hospital, Melbourne"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Melbourne Department of Paediatrics, Murdoch Childrens Research Institute and Royal Children's Hospital, Melbourne","institution_ids":["https://openalex.org/I1321649718","https://openalex.org/I165779595","https://openalex.org/I4210150290"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5037170976","display_name":"Ross M Andrews","orcid":"https://orcid.org/0000-0001-6220-9019","observed_orcids":["https://orcid.org/0000-0001-6220-9019"]},"institutions":[{"id":"https://openalex.org/I29894533","display_name":"Charles Darwin University","ror":"https://ror.org/048zcaj52","country_code":"AU","type":"education","lineage":["https://openalex.org/I29894533"]},{"id":"https://openalex.org/I4210085939","display_name":"Menzies School of Health Research","ror":"https://ror.org/006mbby82","country_code":"AU","type":"nonprofit","lineage":["https://openalex.org/I29894533","https://openalex.org/I4210085939"]}],"countries":["AU"],"is_corresponding":false,"raw_author_name":"R. Andrews","raw_affiliation_strings":["Menzies School of Health Research, Charles Darwin University, Darwin, Australia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Menzies School of Health Research, Charles Darwin University, Darwin, Australia","institution_ids":["https://openalex.org/I29894533","https://openalex.org/I4210085939"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":8,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":4763,"currency":"USD","value_usd":4763},"apc_paid":null,"fwci":15.7124,"has_fulltext":false,"cited_by_count":264,"citation_normalized_percentile":{"value":0.99446595,"is_in_top_1_percent":true,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":99,"max":100},"biblio":{"volume":"59","issue":"3","first_page":"358","last_page":"365"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11153","display_name":"Streptococcal Infections and Treatments","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11153","display_name":"Streptococcal Infections and Treatments","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10195","display_name":"Antimicrobial Resistance in Staphylococcus","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12297","display_name":"Otolaryngology and Infectious Diseases","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/invasive-group-a-streptococcal-disease","display_name":"invasive group A streptococcal disease","score":0.9470000267028809},{"id":"https://openalex.org/keywords/clindamycin","display_name":"clindamycin","score":0.9729999899864197},{"id":"https://openalex.org/keywords/intravenous-immunoglobulin","display_name":"intravenous immunoglobulin","score":1.0},{"id":"https://openalex.org/keywords/streptococcal-toxic-shock-syndrome","display_name":"streptococcal toxic shock syndrome","score":0.9430000185966492},{"id":"https://openalex.org/keywords/necrotizing-fasciitis","display_name":"necrotizing fasciitis","score":0.9919999837875366},{"id":"https://openalex.org/keywords/septic-shock","display_name":"septic shock","score":0.9210000038146973},{"id":"https://openalex.org/keywords/mortality","display_name":"mortality","score":0.8040000200271606},{"id":"https://openalex.org/keywords/household-contacts","display_name":"household contacts","score":0.8289999961853027},{"id":"https://openalex.org/keywords/secondary-transmission","display_name":"secondary transmission","score":0.5370000004768372},{"id":"https://openalex.org/keywords/antibiotic-prophylaxis","display_name":"antibiotic prophylaxis","score":0.9430000185966492},{"id":"https://openalex.org/keywords/active-surveillance","display_name":"active surveillance","score":0.4440000057220459}],"concepts":[{"id":"https://openalex.org/C2777458120","wikidata":"https://www.wikidata.org/wiki/Q422273","display_name":"Clindamycin","level":3,"score":0.8978077173233032},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8842558860778809},{"id":"https://openalex.org/C23131810","wikidata":"https://www.wikidata.org/wiki/Q818574","display_name":"Observational study","level":2,"score":0.6507746577262878},{"id":"https://openalex.org/C501593827","wikidata":"https://www.wikidata.org/wiki/Q12187","display_name":"Antibiotics","level":2,"score":0.6292850375175476},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.5047479867935181},{"id":"https://openalex.org/C2780678043","wikidata":"https://www.wikidata.org/wiki/Q743241","display_name":"Group A","level":2,"score":0.44378426671028137},{"id":"https://openalex.org/C177713679","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Intensive care medicine","level":1,"score":0.39137983322143555},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.3750280737876892},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3100171387195587},{"id":"https://openalex.org/C89423630","wikidata":"https://www.wikidata.org/wiki/Q7193","display_name":"Microbiology","level":1,"score":0.17161810398101807},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.0}],"mesh":[{"descriptor_ui":"D000293","descriptor_name":"Adolescent","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000369","descriptor_name":"Aged, 80 and over","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000900","descriptor_name":"Anti-Bacterial Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D002648","descriptor_name":"Child","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002675","descriptor_name":"Child, Preschool","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002981","descriptor_name":"Clindamycin","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011159","descriptor_name":"Population Surveillance","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011446","descriptor_name":"Prospective Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012306","descriptor_name":"Risk","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012772","descriptor_name":"Shock, Septic","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D012772","descriptor_name":"Shock, Septic","qualifier_ui":"Q000453","qualifier_name":"epidemiology","is_major_topic":false},{"descriptor_ui":"D013290","descriptor_name":"Streptococcal Infections","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D013290","descriptor_name":"Streptococcal Infections","qualifier_ui":"Q000453","qualifier_name":"epidemiology","is_major_topic":true},{"descriptor_ui":"D013291","descriptor_name":"Streptococcus","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D013291","descriptor_name":"Streptococcus","qualifier_ui":"Q000302","qualifier_name":"isolation & purification","is_major_topic":false},{"descriptor_ui":"D014739","descriptor_name":"Victoria","qualifier_ui":"Q000453","qualifier_name":"epidemiology","is_major_topic":false},{"descriptor_ui":"D015994","descriptor_name":"Incidence","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016756","descriptor_name":"Immunoglobulins, Intravenous","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D019115","descriptor_name":"Fasciitis, Necrotizing","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D019115","descriptor_name":"Fasciitis, Necrotizing","qualifier_ui":"Q000453","qualifier_name":"epidemiology","is_major_topic":false},{"descriptor_ui":"D055815","descriptor_name":"Young Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":3,"locations":[{"id":"doi:10.1093/cid/ciu304","doi":"https://doi.org/10.1093/cid/ciu304","is_oa":false,"landing_page_url":"https://doi.org/10.1093/cid/ciu304","pdf_url":null,"source":{"id":"https://openalex.org/S72350973","display_name":"Clinical Infectious Diseases","issn_l":"1058-4838","issn":["1058-4838","1537-6591"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Infectious Diseases","raw_type":"journal-article"},{"id":"pmid:24785239","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/24785239","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical infectious diseases : an official publication of the Infectious Diseases Society of America","raw_type":"Journal Article"},{"id":"pmh:oai:pure.atira.dk:openaire/e8c6ee00-d6f6-48e2-8a9f-6567210db2a0","doi":null,"is_oa":true,"landing_page_url":"https://research-repository.uwa.edu.au/en/publications/e8c6ee00-d6f6-48e2-8a9f-6567210db2a0","pdf_url":null,"source":{"id":"https://openalex.org/S4306402492","display_name":"UWA Profiles and Research Repository (UWA)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I177877127","host_organization_name":"The University of Western Australia","host_organization_lineage":["https://openalex.org/I177877127"],"host_organization_lineage_names":[],"type":"repository"},"license":"other-oa","license_id":"https://openalex.org/licenses/other-oa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Carapetis, J, Jacoby, P, Carville, K S, Ang, S J J, Curtis, N C & Andrews, R M 2014, 'Effectiveness of clindamycin and intravenous immunoglobulin, and risk of disease in contacts, in invasive group a streptococcal infections', Clinical Infectious Diseases, vol. 59, no. 3, pp. 358-365. https://doi.org/10.1093/cid/ciu304","raw_type":"info:eu-repo/semantics/article"}],"best_oa_location":{"id":"pmh:oai:pure.atira.dk:openaire/e8c6ee00-d6f6-48e2-8a9f-6567210db2a0","doi":null,"is_oa":true,"landing_page_url":"https://research-repository.uwa.edu.au/en/publications/e8c6ee00-d6f6-48e2-8a9f-6567210db2a0","pdf_url":null,"source":{"id":"https://openalex.org/S4306402492","display_name":"UWA Profiles and Research Repository (UWA)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I177877127","host_organization_name":"The University of Western Australia","host_organization_lineage":["https://openalex.org/I177877127"],"host_organization_lineage_names":[],"type":"repository"},"license":"other-oa","license_id":"https://openalex.org/licenses/other-oa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Carapetis, J, Jacoby, P, Carville, K S, Ang, S J J, Curtis, N C & Andrews, R M 2014, 'Effectiveness of clindamycin and intravenous immunoglobulin, and risk of disease in contacts, in invasive group a streptococcal infections', Clinical Infectious Diseases, vol. 59, no. 3, pp. 358-365. https://doi.org/10.1093/cid/ciu304","raw_type":"info:eu-repo/semantics/article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":1.0,"display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/observational-study","display_name":"Observational Study"}],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":29,"referenced_works":["https://openalex.org/W139211453","https://openalex.org/W1635000064","https://openalex.org/W1787330966","https://openalex.org/W1946686681","https://openalex.org/W1997586520","https://openalex.org/W2006887913","https://openalex.org/W2013760221","https://openalex.org/W2035281728","https://openalex.org/W2040060164","https://openalex.org/W2082173774","https://openalex.org/W2106129941","https://openalex.org/W2124651059","https://openalex.org/W2128052596","https://openalex.org/W2128625547","https://openalex.org/W2130348108","https://openalex.org/W2133036129","https://openalex.org/W2135026239","https://openalex.org/W2147547119","https://openalex.org/W2147556611","https://openalex.org/W2159958330","https://openalex.org/W2163988158","https://openalex.org/W2170670022","https://openalex.org/W2171780167","https://openalex.org/W2325466288","https://openalex.org/W2415908093","https://openalex.org/W2588571229","https://openalex.org/W2620052693","https://openalex.org/W3154259764","https://openalex.org/W4245451326"],"related_works":["https://openalex.org/W3196168956","https://openalex.org/W2130528985","https://openalex.org/W1500893124","https://openalex.org/W7130614812","https://openalex.org/W2205696222","https://openalex.org/W2337314562","https://openalex.org/W2068904197","https://openalex.org/W4385797804","https://openalex.org/W4284681821","https://openalex.org/W1975558395"],"abstract_inverted_index":{"BACKGROUND:":[0],"The":[1,131,175,224],"use":[2],"of":[3,11,54,60,75,135,165,172,178,203,228,237],"clindamycin":[4,150,201],"and":[5,18,149,212],"intravenous":[6],"immunoglobulin":[7],"(IVIG)":[8],"in":[9,24,142,169,181,194],"treatment":[10,202,221],"invasive":[12],"group":[13],"A":[14],"streptococcal":[15],"(iGAS)":[16],"infection,":[17],"the":[19,41,58,124,136,191,238],"need":[20],"for":[21,138,245],"prophylactic":[22],"antibiotics":[23],"close":[25],"contacts,":[26],"remains":[27],"contentious.":[28],"Controlled":[29],"trials":[30],"are":[31],"unlikely":[32],"to":[33,44],"be":[34,217],"conducted,":[35],"so":[36],"prospective,":[37,51],"observational":[38],"studies":[39],"provide":[40],"best":[42],"data":[43,198],"inform":[45],"practice.":[46],"METHODS:":[47],"We":[48],"conducted":[49],"population-based,":[50],"active":[52],"surveillance":[53],"iGAS":[55,77,166,179,207,229],"infections":[56,208],"throughout":[57],"state":[59],"Victoria,":[61],"Australia":[62],"(population":[63],"4.9":[64],"million),":[65],"from":[66],"March":[67],"2002":[68],"through":[69],"August":[70],"2004.":[71],"RESULTS:":[72],"Eighty-four":[73],"cases":[74,164],"severe":[76,98,206],"infection":[78,167],"(streptococcal":[79],"toxic":[80],"shock":[81],"syndrome,":[82],"necrotizing":[83],"fasciitis,":[84],"septic":[85],"shock,":[86],"or":[87],"GAS":[88],"cellulitis":[89],"with":[90,159,205,222],"shock)":[91],"were":[92],"identified.":[93],"Clindamycin-treated":[94],"patients":[95,102,144,153,204],"had":[96],"more":[97],"disease":[99,180,230],"than":[100,190],"clindamycin-untreated":[101,160],"but":[103],"lower":[104,128,141],"mortality":[105,139,211],"(15%":[106],"vs":[107],"39%;":[108],"odds":[109],"ratio":[110],"[OR],":[111],"0.28;":[112],"95%":[113,146,155],"confidence":[114],"interval":[115],"[CI],":[116],".10-.80).":[117],"Among":[118],"those":[119],"who":[120],"received":[121],"concurrent":[122,220],"IVIG,":[123],"fatality":[125],"rate":[126,177],"was":[127,140,183],"still":[129],"(7%).":[130],"adjusted":[132],"point":[133],"estimate":[134],"OR":[137],"clindamycin-treated":[143],"(0.31;":[145],"CI,":[147,156,186],".09-1.12)":[148],"plus":[151],"IVIG-treated":[152],"(0.12;":[154],".01-1.29)":[157],"compared":[158],"patients.":[161],"Three":[162],"confirmed":[163],"occurred":[168],"household":[170,232],"contacts":[171,182,233],"index":[173,239],"cases.":[174],"incidence":[176,193],"2011":[184],"(95%":[185],"413-5929)":[187],"times":[188],"higher":[189],"population":[192],"Victoria.":[195],"CONCLUSIONS:":[196],"Our":[197],"suggest":[199],"that":[200,213],"substantially":[209],"reduces":[210],"this":[214],"effect":[215],"may":[216],"enhanced":[218],"by":[219],"IVIG.":[223],"dramatically":[225],"increased":[226],"risk":[227],"among":[231],"within":[234],"1":[235],"month":[236],"case":[240],"highlights":[241],"a":[242],"potential":[243],"role":[244],"antibiotic":[246],"prophylaxis.":[247]},"counts_by_year":[{"year":2026,"cited_by_count":19},{"year":2025,"cited_by_count":23},{"year":2024,"cited_by_count":21},{"year":2023,"cited_by_count":14},{"year":2022,"cited_by_count":17},{"year":2021,"cited_by_count":27},{"year":2020,"cited_by_count":37},{"year":2019,"cited_by_count":14},{"year":2018,"cited_by_count":20},{"year":2017,"cited_by_count":17},{"year":2016,"cited_by_count":17},{"year":2015,"cited_by_count":23},{"year":2014,"cited_by_count":14}],"updated_date":"2026-11-12T12:28:57.059296","created_date":"2016-06-24T00:00:00"}